When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

What happened with Novo Nordisk stock? On Dec. 20, Novo announced results from a phase 3 clinical trial surrounding one of ...

Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.

So is Ozempic safe? Novo Nordisk, the pharmaceutical company that makes Ozempic and Wegovy, stands behind the safety and efficacy of all its GLP-1 medicines when they’re used as indicated and ...

An X post from Elon Musk on Wednesday highlighted Tesla (TSLA) CEO's newfound preference for Eli Lilly's (NYSE:LLY) weight loss therapy Mounjaro over Novo Nordisk's (NVO) rival product Ozempic.

Novo Nordisk (NYSE:NVO) has secured approval from the European Medicines Agency (EMA) for a kidney disease-related label expansion for its blockbuster drug Ozempic (semaglutide) in Europe, on December ...

Ozempic maker Novo Nordisk saw its value fall by as much as £82billion yesterday after a weight loss drug trial fell short of expectations. It was one of the Danish pharma giant's worst days on ...

Since Ozempic blasted onto the stage in 2017 with its approval for type 2 diabetes, drugmakers Novo Nordisk and Eli Lilly have been battling to leapfrog each other with newer and more effective ...